Pasco-Pinellas Oncology — New Port Richey, Florida

Pasco-Pinellas Oncology is a clinical research site located in New Port Richey, Florida, United States 34652.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Pasco-Pinellas Oncology has participated in 1 clinical trials.

Therapeutic areas: Her2 Negative Breast Cancer Patients.

Sponsors: Merrimack Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Port Richey

Browse all research sites in Florida · View every site in New Port Richey

• Morton Plant North Bay Hospital
• Supportive Services for Veterans Families
• Community Hospital
• Suncoast Clinical Research
• Advanced Research Institute
• Research Site
• Pfizer Investigational Site
• GSK Investigational Site
• Florida Cancer Institute
• Novo Nordisk Investigational Site
• Sun Coast Clinical Research
• Florida Cancer Institute-New Hope

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pasco-Pinellas Oncology?

Pasco-Pinellas Oncology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pasco-Pinellas Oncology conducted?

Pasco-Pinellas Oncology has 1 clinical trials on record. Their work covers Her2 Negative Breast Cancer Patients.

Is Pasco-Pinellas Oncology accredited by Crixeo Clinical Trials?

Pasco-Pinellas Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pasco-Pinellas Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.